Business Wire

INTUITUS

12.10.2016 09:09:49 CEST | Business Wire | Press release

Share
Intuitus: Technology ‘Red Flags’ Risk Derailing M&A Warns Top PE Adviser

The MD of one of Europe’s leading private equity advisers has warned that technology and IT ‘red flags’ could put at risk the exits or re-financings of companies that would otherwise be seeing deals get over the line successfully with international and London-based institutions and corporate investors.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161012005052/en/

While various reports have indicated a surge of interest from foreign investors in UK private-equity-owned assets during the second half of 2016 - partly driven by a sharp drop in the value of the pound - that shows signs of continuing into 2017, forward planning in the twelve months leading up to the exit can have a huge impact not only on deal value but whether the deal concludes.

Fixing technology and IT operations can require considerable time and effort, warns Intuitus MD and founder, Calum Stewart:

“Technology has never been more critical to exit readiness than it is today and our client base consistently tells us that if IT problems are discovered in the lead-up to exit it is often too late to redress the situation before potential buyers start taking a look. Potential issues and deal-breakers include intellectual property disputes, contractual disputes, capacity planning and product development problems.”

“In a typical sale process, any significant technology or IT problem presenting a current or future risk will be likely to delay the process and may also depreciate the value that you’re trying to extract. In the worst instance, it could even derail the sale completely.”

  • Intuitus - whose private equity clients include Inflexion, The Carlyle Group, Dunedin, Triton and Scottish Equity Partners - is in on track to advise on over 100 deals during 2016, with approximately 30% of deal activity involving non-UK assets.
  • Intuitus offers its private equity and corporate clients commercially-focused, independent technology and IT expertise throughout the full investment life cycle - at the point of acquisition, during ownership and at exit. Supported by a network of internationally-experienced consultants, mainly former CEOs, CTOs, CIOs and IT Directors from a wide range of industry sectors, and managed through the company’s unique, integrated delivery model, the company is targeting expansion in the UK, Benelux, France, Germany and the Nordics in 2017.
  • Intuitus won the Specialist Adviser of the Year award at The Private Equity Awards 2016.

Follow Intuitus on LinkedIn and Twitter

Contact:

Intuitus
Calum Stewart
+44 (0)131 618 0512
or
Freer Consultancy
Nick Freer
+44 (0)7841 571 871
nick@freerconsultancy.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IFF Reports Third Quarter 2026 Results3.11.2026 22:30:00 CET | Press release

Delivered Strong Sales, Profit and Cash Flow Performance in Third Quarter 2026Raising Low-End of Full Year 2026 Financial Guidance RangesRecently Completed $500M Share Repurchase AuthorizationFood Ingredients Divestiture Progressing Well and On Track to Close by End of Second Quarter 2027 IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2026. Results are presented on a continuing operations basis, excluding the Food Ingredients business and other minor perimeter adjustments (the “Food Ingredients disposal group”), and the Soy Crush, Concentrates, and Lecithin businesses (the “SCL disposal group”). The Food Ingredients disposal group and the SCL disposal group are reported as discontinued operations. Management Commentary “IFF delivered a solid third quarter, with improved sales and profitability across all divisions,” said Erik Fyrwald, CEO of IFF. “Taste and Scent delivered strong top- and bottom-line results, and Health & Biosciences improved modes

2026–2027 World Branding Awards Honours Global “Brand of the Year” Winners at Hampton Court Palace3.11.2026 21:00:00 CET | Press release

The World Branding Awards returned to honour the brands that continue to set the benchmark for excellence. The 2026–2027 World Branding Awards Ceremony took place at the iconic Hampton Court Palace, marking the 21st edition of the awards. Set within the grandeur of a historic venue, the prestigious event brought together guests from across the globe for a memorable celebration. The evening was hosted by the acclaimed BBC presenter, Hannah Gray, and was further enriched by a keynote presentation from renowned speaker Adrian Webster. Earning a World Branding Awards remains a highly distinguished achievement. Winners are determined through a rigorous evaluation process encompassing brand valuation, consumer market research, and public online voting. This year, over 105,000 consumers took part in the voting process, and more than 2,000 brands from 62 countries were nominated. Of these, less than 10 brands from each country were declared the “Brand of the Year” across the Global, Regional,

Gencom Acquires Rosewood London, Expanding Its Footprint With Its First Luxury Hotel Acquisition in Europe3.11.2026 19:05:00 CET | Press release

Located in one of the world’s most prestigious hospitality corridors, the acquisition of the 308-key hotel represents a major milestone in the firm’s international growth. Gencom, a U.S.-based investment firm that owns and develops prized real estate around the world, announces the acquisition of Rosewood London, the landmark 308-key luxury hotel situated at 252 High Holborn in Central London. The acquisition strengthens Gencom’s global hospitality investment platform and expands its presence in Europe through its first luxury hotel asset in London. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103137897/en/ Gencom, a U.S.-based investment firm that owns and develops prized real estate around the world, announces the acquisition of Rosewood London in Central London London is one of the world’s most supply-constrained hospitality markets, supported by year-round demand from both leisure and business travelers. The acquisi

SGCA Honours Communication Excellence Across Asia, Europe and the Arab World3.11.2026 16:52:00 CET | Press release

His Highness Sheikh Dr Sultan bin Ahmed bin Sultan Al Qasimi, Deputy Ruler of Sharjah and Chairman of the Sharjah Media Council, honoured winners of the 13th Sharjah Government Communication Award (SGCA), organised by the Sharjah Government Media Bureau (SGMB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103972039/en/ SGCA honours communication excellence across Asia, Europe and the Arab world (Photo: AETOSWire) Winners represented China, India, Thailand, Ukraine and the Arab world. Some 433 entries from 31 countries across four continents passed initial screening. The award covered 23 categories across five sectors, including six partner awards. His Excellency Tariq Saeed Allay, Director General of SGMB, highlighted the award’s growth under the vision of His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, noting that it had attracted more than 9,500 entries over five year

BioLife to Showcase Oral Peptide Delivery Technology During London Life Sciences Week3.11.2026 16:03:00 CET | Press release

Company to highlight granted patent portfolio, preclinical semaglutide data and potential applications across future peptide medicines at LSX Investival BioLife Products Limited today announced its participation in London Life Sciences Week, where it will highlight its patented oral peptide delivery technology and recent advances in its intellectual property portfolio. BioLife will present at the LSX Investival Showcase on Monday, November 16, 2026, from 3:15 to 3:30 p.m. GMT, at Old Billingsgate, London. The presentation will be led by Former US Ambassador James P. Cain, Strategic Advisor to the Chairman & Founder, alongside Ludivine Delattre, Business and Corporate Relations, and will highlight the scientific journey behind the technology and its potential applications. BioLife is focused on developing a novel approach to delivering peptide therapeutics orally. Built on over 35 years of pharmaceutical effervescence expertise and two decades of oral peptide research by founder and inv

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye